A Trial to Determine the Efficacy and Safety of Presendin in IIH

Clinical trial NCT05347147 · TERMINATED

Trial details

NCT number: NCT05347147
Sponsor: Invex Therapeutics Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Intracranial Hypertension

Start date: 2022-11-18
Primary completion: 2023-09-18
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.